An interventional study of IMPEDE-FX Embolization Plug in Abdominal Aortic Aneurysm, sponsored by Shape Memory Medical, Inc.. Active, not recruiting at 3 sites in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-22.
Sponsored by Shape Memory Medical, Inc. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 62 studies in Aortic Aneurysm, Abdominal with a site in Netherlands — 14 open to participants now, 22 under way, none of them phase 3. Aortic Aneurysm, Abdominal · Netherlands.
Among the 62 studies in Aortic Aneurysm, Abdominal with a site in Netherlands, this one is the 19th largest by enrollment of the 22 interventional ones that give a count, is one of 3 that started in 2021, is one of 18 with no phase, reaches primary completion later than 1 of the 21 other live ones, and was the 44th registered.
467 studies on the registry are indexed under Aortic Aneurysm, Abdominal; 99 are open to participants now.
Browse Aortic Aneurysm, Abdominal studies →14 of the 62 studies in Aortic Aneurysm, Abdominal with a site in Netherlands are open now. Recruiting first, the newest first:
Leiden University Medical Center · Sites in Netherlands
Ages 18+
JOTEC GmbH · Sites in Netherlands
Ages 18+
iVascular S.L.U. · Sites in Netherlands, Belgium, France and 2 more countries
Ages 55+
W.L.Gore & Associates · Sites in Netherlands, United States, Australia and 10 more countries
Ages 18+
Amsterdam UMC, location VUmc · Sites in Netherlands, Finland, Germany and 3 more countries
Ages 40–90
A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →
Of the 66 Aortic Aneurysm, Abdominal studies recruiting now, 52 (79%) set no upper age limit and 3 (5%) stop at 75 or younger; 2 take children under 18; 8 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
62 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 3 started in 2021.
This study's enrollment of 15 is below the median of 66 across 228 interventional studies indexed under Aortic Aneurysm, Abdominal.
Median enrollment 67 across the 22 interventional studies, 153 across the 40 observational. Of the 35 that completed or were terminated, 6 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
29 of 62 have an industry lead sponsor. The 10 most frequent:
Shape Memory Medical, Inc. is the lead sponsor of 8 studies on the registry; 3 are open to participants now.
Shape Memory Medical, Inc. has 3 studies filed under Aortic Aneurysm, Abdominal — fewer than ten, so there is no comparison to draw.
5 of the studies in Aortic Aneurysm, Abdominal with a site in Netherlands that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04307992TripleMed B.V.AneuFix - Prophylactic Sac Filling | 2026-11-30 |
| NCT04183426Rijnstate HospitalTonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to be Treated Patients With an AAA | 2026-12 |
| NCT07312565Leiden University Medical CenterOccurrence of Abdominal Aortic Aneurysms in Patients With Aneurysmal Subarachnoid Hemorrhage | 2026-12-01 |
| NCT05378347Medtronic CardiovascularEndurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial | 2027-05 |
| NCT06029660Shape Memory Medical, Inc.AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion | 2027-07 |
Add all 5 to your calendar (.ics) → With an account.
Among the 62 studies in Aortic Aneurysm, Abdominal with a site in Netherlands, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To determine the safety and efficacy of IMPEDE-FX Embolization Plug and/or IMPEDE-FX Rapid Fill to fill an abdominal aortic aneurysm (AAA) sac outside of an endovascular aneurysm repair (EVAR) stent graft.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: IMPEDE-FX Embolization Plug
Fill an abdominal aortic aneurysm (AAA) sac outside of an endovascular aneurysm repair (EVAR) stent graft
Incidence of related major adverse events (MAEs)
Incidence of related major adverse events (MAEs)
Time frame: 30 days post-procedure
Efficacy - Technical Success
Technical success, defined as filling of the residual flow lumen of the AAA sac with investigational products
Time frame: Immediately after the intervention
Incidence of related major adverse events (MAEs)
Incidence of related major adverse events (MAEs)
Time frame: 5 years post-procedure
Incidence of related serious adverse events (SAEs)
Incidence of related serious adverse events (SAEs)
Time frame: 5 years post-procedure
Efficacy - Type II endoleaks
Incidence of type II endoleaks
Time frame: 5 years post-procedure
Efficacy - Type I and type III endoleaks
Incidence of type I and type III endoleaks
Time frame: 5 years post-procedure
Efficacy - AAA sac diameter/volume
Change in AAA sac diameter/volume
Time frame: 5 years post-procedure
Efficacy - Open repair
Rate of conversion to open AAA repair
Time frame: 5 years post-procedure
Efficacy - Reinterventions
Rate of other reinterventions related to the AAA sac growth and/or complications
Time frame: 5 years post-procedure
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2021 to primary completion in Apr 2022, 9 months.
Of 43 industry-sponsored interventional studies with no phase under Aortic Aneurysm, Abdominal, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 73. This study's 9 months is below that.
Counting every sponsor, half of 94 studies reached it within 43 months; a quarter within 23 and three quarters within 65.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shape Memory Medical, Inc.